AMA CPT® Assistant - 2024 Issue 6 (June)
Reporting Pathology and Laboratory Codes 81517, 82166, 87523 (June 2024)
June 2024 pages 1-13 Reporting Pathology and Laboratory Codes 81517, 82166, 87523 For the Current Procedural Terminology (CPT®) 2024 code set, several new pathology and laboratory codes (81517, 82166, 87523) and guideline revisions were established to report laboratory services or procedures that were formerly not represented by specific subsection codes. Code 81517 was added to the Multianalyte Assays with Algorithmic Analyses (MAAA) subsection to report testing for liver disease by analyzing three biomarkers; code 82166 was added to the Chemistry subsection to report anti-mullerian hormone (AMH) assay; and code 87523 was added to the Microbiology subsection to report...
Subscribe or sign in to view the full article.
Article Overview
This article explains CPT® 2024 updates affecting pathology and laboratory reporting, with emphasis on newly established codes, related guideline revisions, and cross-reference notes. It is intended for coders, laboratory billing staff, compliance teams, and clinicians who need to understand the scope of the updates and how the affected laboratory subsections are organized.
Why This Topic Matters
Laboratory coding changes can affect claim accuracy, reporting consistency, and documentation alignment across multiple specialties and test types. This article helps readers identify where CPT® guidance changed and which laboratory topics are covered in the update.
Article Sections
-
Multianalyte Assays with Algorithmic Analyses
Covers a CPT® laboratory subsection update involving a multianalyte assay and associated reporting guidance. The section situates the change within the broader pathology and laboratory code structure.
-
Chemistry
Summarizes a chemistry subsection update and related guideline clarification for laboratory analyte reporting. The section also notes the broader reporting context within the chemistry code range.
-
Microbiology
Describes a microbiology subsection update involving infectious agent testing and related cross-reference revisions. The section places the change in the context of hepatitis-related laboratory reporting.
-
Clinical Examples and Procedural Descriptions
Provides example scenarios and procedure descriptions associated with the newly discussed laboratory codes. This material illustrates the general clinical contexts addressed by the article.
What You Will Learn
- Which pathology and laboratory subsections were updated in CPT® 2024
- How the article frames the purpose of newly established laboratory codes
- What kinds of guideline and cross-reference changes accompany the update
- How the article organizes clinical examples and procedural descriptions for the affected laboratory topics
Who Should Read This
- Medical coders
- Laboratory billing staff
- Compliance professionals
- Pathology and laboratory administrators
- Clinicians involved in test ordering and documentation
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com